We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PCAR:NASDAQPACCAR Inc. Analysis

Data as of 2026-09-07 - not real-time

$124.70

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

PACCAR Inc trades at $124.70, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it lost 5.7%. Relative strength is 42.4 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $121.18 and resistance around $133.71.
Multiples put this in fair territory: 26.3 times earnings against the sector's 28.5. The average analyst target implies 15.0% above today's level. The 1.12% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 23.4%, a beta of 0.97 and a maximum drawdown of 15.6%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 4/10 conviction over the longer horizon.

Top Market Events

Trucking company PACCAR NASDAQ:PCAR in Q2 CY2026, but sales were flat year on year at $7.PACCAR crushed expectations with a 5.4% EPS beat and 7.4% revenue beat as truck-segment profitability surged on strong...PACCAR Inc PCAR reports a robust second quarter with record revenues, increased truck deliveries, and strategic...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 119.83
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 26.3 versus sector average of 28.5
  • Trading above the 200-day average of 119.83

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • P/E of 26.3 versus sector average of 28.5
  • Analyst targets imply +15.0% versus the current price
  • Dividend yield of 1.12%

Key Metrics & Analysis

Financial Health

Revenue Growth0.50%
Profit Margin9.00%
P/E Ratio26.3
ROE12.76%
ROA4.12%
Debt/Equity72.91
P/B Ratio3.2
Op. Cash Flow$4.3B
Free Cash Flow$1.9B
Industry P/E28.5

Technical Analysis

TrendBullish
RSI42.4
Support$121.18
Resistance$133.71
MA 20$128.04
MA 50$127.80
MA 200$119.83
MACDBearish
VolumeDecreasing
Fear & Greed Index94.11

Valuation

Fair Value$36.09
Target Price$143.47
Upside/Downside15.05%
GradeFair
TypeBlend
Dividend Yield1.12%

Risk Assessment

Beta0.97
Volatility23.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.